PREMARIN

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Hong Kong SAR China, Ireland, Japan, Malta, Mexico, New Zealand, Singapore, UK.

Active ingredients

The drug PREMARIN contains one active pharmaceutical ingredient (API):

1	Estrogens, conjugated UNII IU5QR144QX - ESTROGENS, CONJUGATED
	The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estrogens, conjugated

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PREMARIN Coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PREMARIN Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)
PREMARIN Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
PREMARIN Vaginal cream	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA57	Conjugated estrogens	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA57

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522719120082407, 522719120082507
CA	Health Products and Food Branch	02043386, 02043440, 02414678, 02414686, 02414694
GB	Medicines & Healthcare Products Regulatory Agency	114769, 26873, 26881, 336714
HK	Department of Health Drug Office	29753, 29754, 29755, 29759
IE	Health Products Regulatory Authority	62063, 62071
JP	医薬品医療機器総合機構	2479004F1033
MT	Medicines Authority	AA565/22704
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	31395, 44321
NZ	Medicines and Medical Devices Safety Authority	587, 588
SG	Health Sciences Authority	03229P, 04484P, 04706P
US	FDA, National Drug Code	0046-0749, 0046-0872, 0046-1100, 0046-1101, 0046-1102, 0046-1103, 0046-1104, 50090-0167